Clinical Trial Update: Study to Evaluate Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Who Are Hyporesponsive to Erythropoiesis Stimulating Agents [Phase 2]

View source ↗

Summary

Phase 2 study evaluating vadadustat for anemia in dialysis-dependent CKD patients who are hyporesponsive to ESAs; terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Dialysis-dependent Chronic Kidney Disease

Drugs mentioned

• Vadadustat (vadadustat)

Snippet

Sponsor: Akebia Therapeutics | Conditions: Anemia, Dialysis-Dependent Chronic Kidney Disease | Phase 2 | Status: TERMINATED | Results posted: 2021-02-21